Literature DB >> 16285592

[A case of drug-induced pneumonia possibly associated with simvastatin].

Sumako Yoshioka1, Hiroshi Mukae, Hiroshi Ishii, Seiko Nakayama, Keiko Hisatomi, Hiroshi Ishimoto, Tomoyuki Kakugawa, Kanako Sugiyama, Mioko Ide, Shigeru Kohno.   

Abstract

A 59-year-old woman was admitted because of general fatigue, cough and progressive dyspnea about 5 months after treatment with simvastatin for hyperlipidemia. A chest radiograph and computed tomography scans revealed ground glass and reticular opacities in the right middle and lower lung fields. The percentage of peripheral blood eosinophils was elevated. After simvastatin was discontinued and administration of prednisolone was started, eosinophilia and reticular shadows improved. Drug lymphocyte stimulation test (DLST) for simvastatin was positive, so we diagnosed drug induced eosinophilic pneumonia. Now hyperlipidemia is treated frequently with HMG-CoA reductase inhibitor, but there are few reports demonstrating lung injury by this drug. We should be aware of lung side effects of HMG-CoA reductase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285592

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Eosinophilic pneumonia associated with pirfenidone therapy.

Authors:  Diana C Gomez; Borna Mehrad
Journal:  Eur Respir J       Date:  2016-07-07       Impact factor: 16.671

2.  Piperacillin-associated pulmonary infiltrates with eosinophilia: a case report.

Authors:  Olivia Ling-I Tseng; John Thomas Kelsall; Pearce George Wilcox
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

Review 3.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.